CannLabs Continues to Make Tremendous Strides
Ryan Allway
July 17th, 2014
News, Top Story
CannLabs, Inc. (OTCQB: CANL), a solutions provider with intellectual property, proprietary cloud-based analytics, and scientific methods to serve the cannabis industry, recently announced a series of moves that help to solidify its position within the rapidly growing U.S. cannabis industry, which some analysts believe will reach $2.57 billion in size in 2014.*
In this article, we’ll take a look at some of the recent strides that the company has made towards building long-term shareholder value.
New Leadership
On July 15, 2014 CannLabs announced the addition of industry leaders and management experts to its executive team to support the company’s growth plans. This included naming Mr. Mark C. Mirken as Chief Executive Officer; CannLabs founder, Genifer Murray named President; Steve Kilts assumed an expanded position as Chief Operating Officer and Chief Strategist; and Mark Rogers, who was elected as Chairman of the Board of Directors.
“We are excited that Mark has accepted the chief executive role with CannLabs,” said CannLabs Founder and President Genifer Murray. “As we embark upon our expansion, and research and development, the time was right to bring in a seasoned executive with public company experience. I look forward to working with Mark, Steve, and Mark to build a world-class team and further enhance our leadership.”
Read the full press release discussing these appointments:
http://www.cannlabs.com/wp-content/uploads/2014/06/canl_executive_changes_news_release.pdf
Core Services Continue to Grow
As the Colorado Marijuana Enforcement Division (“MED”) continues to rollout testing requirements for infused edibles and other products, CannLabs has been preparing to manage the process with minimal interruption to clients. On July 14th, the company announced that its team is ready to help marijuana infused product makers (MIPs) ensure that they meet these mandated requirements, including the new homogeneity testing.
“We are prepared and ready to support our clients with this new process,” said CannLabs Laboratory Director Heather Despres. “We’ve increased our team and our proprietary customized work-flow software will allow us to manage the added data content easily without any delays to our most important asset – our customers. We’re here to ensure that all state guidelines are met and customers are safe.”
Read the entire press release discussing the new requirements:
CannLabs Commences Trading Under New Ticker Symbol
CannLabs announced that its ticker symbol would be changing from “SDSPD” to “CANL” on July 11th in order to complete its move to a publicly traded company. While these changes have taken some time to be updated across many financial portals and brokerage firms, the move represents another step towards creating long-term brand awareness and shareholder value for investors.
“We are happy to start trading under the new symbol which is directly reflective of our name and business,” said CannLabs Founder and President Genifer Murray. “Shareholders, clients, and the broader investment community will be able to recognize the ticker and [it] is another step in creating brand awareness and shareholder value.”
Read the entire press release announcing the ticker change:
http://www.cannlabs.com/wp-content/uploads/2014/07/CANL-New-Ticker-Symbol-Press-Release-Final.pdf
Looking Ahead
CannLabs is uniquely positioned within the cannabis testing space to offer many more ancillary services to the industry including consulting and research. This is strengthened further given management’s extensive experience and existing operations. Investors in established companies like GW Pharmaceuticals Inc. (NASDAQ: GWPH) or relatively new companies like Cannabis Sativa Inc. (OTCBB: CBDS) may want to take a closer look at the company given its near-term catalysts and unique market exposure.
For more information, see the following resources:
* ArcView Group (http://arcviewgroup.com/)
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.
Jushi and its trade main administration crew is constructing a built-in multi-state proprietor and operator of cannabis and hemp licenses throughout America. Jushi is concentrated on persevering with to construct a various multi-state portfolio of branded cannabis and hemp-derived property by means of opportunistic investments and by internally pursuing licenses in enticing jurisdictions. Jushi strives […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
